Form 4: Dexcom EVP Sadie Stern Sells Shares to Cover Tax Obligations

Sadie Stern, EVP and Chief HR Officer of Dexcom Inc., sold 426 shares of common stock on September 9, 2024, to cover tax withholding obligations related to vesting RSUs.

Summary

• Sadie Stern, the EVP and Chief HR Officer of Dexcom Inc., reported a transaction involving the sale of company stock.
• On September 9, 2024, Stern sold 426 shares of Dexcom common stock at a price of $69.15 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following the transaction, Stern beneficially owns 75,451 shares of Dexcom common stock, which includes 52,323 unvested restricted stock units granted on various dates.

Sentiment

Score: 7

Explanation: The document is neutral in tone and describes a routine transaction. The sale is related to tax obligations, which is a normal part of executive compensation. There is no indication of any negative sentiment or concern.

Industry Context

Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The sale itself is unlikely to have a significant impact on Dexcom's stock price, as it is a relatively small transaction.

Comparison to Industry Standards

• Executive compensation practices, including the use of RSUs and 'sell to cover' tax strategies, are standard across publicly traded companies, including Dexcom's competitors like Medtronic, Abbott, and Senseonics.
• The size of the transaction is small compared to the overall trading volume of Dexcom shares, suggesting minimal impact on the market.

Key Dates